Clec9A–M2e

N/A

Report date: 2025/03/14 16:24:49

Base Information

Drug NameClec9A–M2e
Drug Alias NameM2e peptide vaccine (National University of Singapore/Monash University)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccine
Mechanisms of ActionMatrix protein 2 inhibitors
TargetsMatrix protein 2
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingaporeAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational University Of Singapore
China Registration ClassN/A

Develop Information

Active CompaniesMonash UniversityNational University Of Singapore
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A